Dhanalakshmi Solaimalai
Overview
Explore the profile of Dhanalakshmi Solaimalai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Solaimalai D, Varghese R, Karumathil S, Kulkarni U, George B, Michael J
Med Mycol
. 2024 Oct;
62(10).
PMID: 39394658
Invasive Aspergillosis (IA) is a potentially lethal infection in high-risk haemato-oncology patients. Since traditional diagnostic methods have many inherent challenges, Polymerase Chain Reaction (PCR) has been used to diagnose IA....
2.
Bakthavatchalam Y, Jennifer L, Abdullah F, Srinivasan D, Adhiya R, Ashok A, et al.
Indian J Med Microbiol
. 2024 Aug;
51:100695.
PMID: 39094970
Introduction: Biapenem has been recently approved by the Drug Controller General of India for the treatment of complicated urinary tract infections (cUTI). However, there are no assessment studies that evaluate...
3.
Singh K, Anandan S, Sharma A, Kumar S, Solaimalai D, Veeraraghavan B, et al.
J Clin Exp Hepatol
. 2024 Feb;
14(3):101346.
PMID: 38371607
Background: Data on non-O1/non-O139 (NOVC) infection in liver disease is limited. We studied the clinical features and outcome of patients with cirrhosis with non-NOVC bacteraemia and/or spontaneous bacterial peritonitis (SBP)...
4.
Michael J, Venkatesan M, Ninan M, Solaimalai D, Sumanth L, Varghese L, et al.
Front Cell Infect Microbiol
. 2023 Nov;
13:1251456.
PMID: 38029246
Introduction: Mucormycosis is an acute invasive fungal disease (IFD) seen mainly in immunocompromised hosts and in patients with uncontrolled diabetes. The incidence of mucormycosis increased exponentially in India during the...
5.
Elangovan D, Neeravi A, Sahni R, Santhanam S, Beck M, Adhiya R, et al.
Indian J Med Microbiol
. 2023 Aug;
45:100392.
PMID: 37573061
Invasive group B Streptococcal disease (iGBS) is an important cause of morbidity and mortality in neonates for which the development of an efficacious vaccine remains a global health imperative. The...
6.
Jacob J, Solaimalai D, Rachel T, Pragasam A, Sugumar S, Jeslin P, et al.
Indian J Med Microbiol
. 2022 Aug;
40(4):536-540.
PMID: 35987666
Purpose: Invasive non-typhoidal Salmonella (iNTS) disease is an important cause of morbidity and mortality in African countries. However, the incidence in Indian subcontinent remains poorly documented. This study has assessed...
7.
Solaimalai D, Gupta A, George L, Manesh A, Karthik R, Sathishkumar D, et al.
Front Public Health
. 2022 Aug;
10:908591.
PMID: 35958862
Since 2000, a resurgence of syphilis has been noted in many developed and developing countries, especially among men who have sex with men (MSM). Incidence and prevalence of syphilis in...
8.
Jacob J, Priya T T, Solaimalai D, M Y, Malaiyappan J, Rachel T, et al.
Data Brief
. 2022 Feb;
41:107875.
PMID: 35146093
We report here the draft genome sequence of two rare serotypes, isolated from human faecal samples in India. The isolates were identified as subsp serovar Ceyco and serovar Hillegersberg by...
9.
Bathavatchalam Y, Solaimalai D, Amladi A, Dwarakanathan H, Anandan S, Veeraraghavan B
Future Sci OA
. 2021 Jul;
7(7):FSO710.
PMID: 34258023
Aim: To determine the presence of vancomycin heteroresistance in . Materials & Methods: A total of 48 rifampicin-resistant isolates from bloodstream infections were included. Vancomycin heteroresistance was determined using the...
10.
Pragasam A, Jennifer S, Solaimalai D, Muthuirulandi Sethuvel D, Rachel T, Elangovan D, et al.
Indian J Med Microbiol
. 2020 Nov;
38(3 & 4):313-318.
PMID: 33154241
Background: Aminoglycoside resistance is a growing challenge, and it is commonly mediated by the aminoglycoside-modifying enzymes (AMEs), followed by 16S rRNA methyl transferase. Plazomicin, a novel aminoglycoside agent approved by...